In 2023, Don McDonnell and his team at Duke U developed a drug approved by the FDA used to treat advanced breast cancer

It's the first and only treatment approved to fight breast cancers with mutations in estrogen receptor ESR1

This research was funded by NIH, whose budget was just slashed by DOGE